Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Greinacher

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Thrombosis and Haemostasis|February 29, 2012
Taking advantage of the non-anticoagulant effects of heparinA Greinacher
Thrombosis and Haemostasis|December 22, 1999
Treatment of heparin-induced thrombocytopeniaA Greinacher
Der Orthopade|August 1, 1996
[Heparin-induced thrombocytopenia. How can the risk of postoperative thrombosis or pulmonary embolism be reduced?]A Greinacher
Seminars in Thrombosis and Hemostasis|January 1, 1995
Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesisA Greinacher
Der Anaesthesist|July 8, 2008
[Suspected heparin-induced thrombocytopenia (HIT) type II]A Greinacher
Deutsche Medizinische Wochenschrift (1946)|November 18, 1998
[Thrombosis risk in activated protein C resistance deficiency?]A Greinacher
Wiener Klinische Wochenschrift|May 23, 1997
[Heparin-induced thrombocytopenia]A Greinacher
Journal of Thrombosis and Thrombolysis|January 13, 2001
Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudinN Lubenow, A Greinacher
Circulation|March 14, 2001
Recombinant hirudin in clinical practice: focus on lepirudinA Greinacher, N Lubenow
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|March 17, 2005
[Thrombosis prophylaxis with heparins in intensive care patients]A Greinacher, D Janssen
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Thrombosis and Haemostasis|February 29, 2012
Taking advantage of the non-anticoagulant effects of heparinA Greinacher
Thrombosis and Haemostasis|December 22, 1999
Treatment of heparin-induced thrombocytopeniaA Greinacher
Der Orthopade|August 1, 1996
[Heparin-induced thrombocytopenia. How can the risk of postoperative thrombosis or pulmonary embolism be reduced?]A Greinacher
Seminars in Thrombosis and Hemostasis|January 1, 1995
Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesisA Greinacher
Der Anaesthesist|July 8, 2008
[Suspected heparin-induced thrombocytopenia (HIT) type II]A Greinacher
Deutsche Medizinische Wochenschrift (1946)|November 18, 1998
[Thrombosis risk in activated protein C resistance deficiency?]A Greinacher
Wiener Klinische Wochenschrift|May 23, 1997
[Heparin-induced thrombocytopenia]A Greinacher
Journal of Thrombosis and Thrombolysis|January 13, 2001
Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudinN Lubenow, A Greinacher
Circulation|March 14, 2001
Recombinant hirudin in clinical practice: focus on lepirudinA Greinacher, N Lubenow
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|March 17, 2005
[Thrombosis prophylaxis with heparins in intensive care patients]A Greinacher, D Janssen
Pageof 17